TrivarX Limited Appendix 4E Preliminary final report TrivarX Limited (A.B.N. 58 008 130 336) Suite 1.01, 117 Camberwell Road, Hawthorn East VIC 3123 1. Details of reporting period Name of entity: TrivarX Limited (the Company) ABN: 58 008 130 336 ...
Appendix 4E - Preliminary Final Report
Filed with ASX · · 12 pages · English
Release
Earlier from TrivarX
- June 2026 Quarterly Activities Report and Appendix 4C
- Stabl-Im clinical trial supply milestone achieved
- CRO Engaged to Advance Stabl-Im Phase 1 Trial
- March 2026 Quarterly Activities Report and Appendix 4C
- Dr Danielle Meyrick appointed as CEO
Later from TrivarX
- Notice of AGM and Closing Date for Director Nominations
- Stabl-Im Clinical Development Update
- 2026 Annual Report
- Corporate Governance Statement
- Appendix 4G
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX